increase in incidence of cancer is driving the Brachytherapy Afterloaders Market
Technavio analyzes that the Brachytherapy Afterloaders Market is expected to grow at a CAGR of 12% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 62.9 million.There are various factors that contribute to the growth of the market. The Brachytherapy Afterloaders Market is experiencing significant growth due to the rising incidence of cancer worldwide. Brachytherapy, a form of internal radiation therapy, is increasingly being adopted for its numerous advantages over traditional external beam radiation therapy. Afterloaders are essential devices used in brachytherapy to deliver radiation doses accurately and safely to the tumor site. With the growing number of cancer patients, the demand for brachytherapy afterloaders is expected to surge in the coming years.
In the realm of cancer treatment, Brachytherapy, specifically High-Dose Rate (HDR) Brachytherapy, emerges as a highly effective internal radiation therapy technique. This method delivers radiation directly to the tumor site through implanted sources, such as seeds or catheters. HDR Brachytherapy utilizes a remote afterloader system, which temporarily positions a single radioactive source near the tumor, ensuring precise dosage delivery. The defined HDR dose exceeds 12 Gray/hour (Gy/h). Notably, this advanced procedure is executed in well-shielded rooms to ensure safety. Varian Medical Systems Inc.'s VariSource iX HDR Afterloader is a prominent solution in this domain, enabling healthcare professionals to administer HDR Brachytherapy efficiently and accurately for breast, prostate, and other cancer types, while minimizing exposure to surviving cancer cells.
Know which region is leading the market growth by requesting a sample report
Brachytherapy Afterloaders Market Segmentation
As per our research findings, here are some of the key competitors that are leading the industry
Find out what is trending in the market by accessing the free PDF report
In the realm of radiation oncology, brachytherapy afterloaders play a crucial role in delivering high-precision, localized radiation treatment for various types of cancer. These devices enable the administration of both high-dose-rate (HDR) and low-dose-rate (LDR) brachytherapy, which are essential for preventive and palliative radiation therapy. HDR brachytherapy, known for its ability to minimize radiotherapy side effects, is particularly effective in cancer screening and treatment of skin cancer, melanoma, leukemia, and lymphoma. LDR brachytherapy, on the other hand, is commonly used for prostate and cervical cancer treatment. Brachytherapy afterloaders are integral to the radiotherapy planning process, ensuring personalized and effective radiation therapy for patients, while mitigating the risks associated with traditional radiotherapy technology.
In the healthcare equipment market, as identified by Technavio, Brachytherapy Afterloaders represent a significant segment. This sector is characterized by the development and production of advanced devices used in radiation therapy, specifically those involving radioactive seeds and image-guided techniques such as ultrasound and magnetic resonance imaging. The geriatric population's growing need for cancer treatment contributes to the market's expansion. Technavio's global healthcare equipment market analysis encompasses the revenues generated by manufacturers of diagnostic equipment and devices, including Brachytherapy Afterloaders, which fall under the capital equipment and consumables categories.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted